| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/18/2011 | EP2322199A1 Growth differentiation factor receptors, and methods of using same |
| 05/18/2011 | EP2322160A1 Methods of inducing terminal differentiation |
| 05/18/2011 | EP2322156A1 Composition for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
| 05/18/2011 | EP2322154A2 Methods for detecting and clearing cross beta structure comprising proteins with crossbeta structure binding compounds. |
| 05/18/2011 | EP2322152A1 Method of preparing a composition comprising a GPR119 agonist |
| 05/18/2011 | EP2322151A2 Sustained release formulation comprising a GPR119 agonist and a DPP-IV inhibitor |
| 05/18/2011 | EP2322150A2 Method of identifying GLP-1 secretagogues |
| 05/18/2011 | EP2322093A1 Method for assaying in vivo component, data processing method for assaying in vivo component and apparatus and collection member for assaying in vivo component |
| 05/18/2011 | EP2322092A1 Method, system, and computer program product for processing of self-monitoring blood glucose (smbg) data to enhance diabetic self-management |
| 05/18/2011 | EP2321652A1 Natriuretic peptides and adiponectin in subjects with a metabolic syndrome |
| 05/18/2011 | EP2321651A1 Identification of subjects being susceptible to anti-angiogenesis therapy |
| 05/18/2011 | EP2321650A1 Azurophilic granule proteases as markers in cardiological diseases |
| 05/18/2011 | EP2321649A2 Automated diagnostic workstation |
| 05/18/2011 | EP2321648A1 Diagnosis of systemic diseases |
| 05/18/2011 | EP2321647A1 Biomarkers for insulin resistance and beta-cell dysfunction |
| 05/18/2011 | EP2321646A1 Method for characterizing, in particular for quantifying, molecular markers that are intracellularly absorbed from tissues by blood macrophages that are recirculated from the tissues into the circulatory system |
| 05/18/2011 | EP2321645A1 Susceptibility to hsp90-inhibitors |
| 05/18/2011 | EP2321644A1 Screening methods for transfusion related acute lung injury (trali) |
| 05/18/2011 | EP2321643A1 Apparatus for hemolyzing a blood sample and for measuring at least one parameter thereof |
| 05/18/2011 | EP2321642A1 Methods for allele calling and ploidy calling |
| 05/18/2011 | EP2321641A2 Gene methylation in cancer diagnosis |
| 05/18/2011 | EP2321636A1 Methods for measurement of fluid electrical stability |
| 05/18/2011 | EP2321629A2 Use of focused light scattering techniques in biological applications |
| 05/18/2011 | EP2321430A2 Method of evaluating oral cancer risk in human |
| 05/18/2011 | EP2321426A1 Compositions for detecting cell death and methods of use thereof |
| 05/18/2011 | EP2321423A1 Method of detecting bioactive molecules in a fluid sample |
| 05/18/2011 | EP2321411A1 Melk epitope peptides and vaccines containing the same |
| 05/18/2011 | EP2321406A1 Method for selecting secondary neurosphere derived from differentiated cell-derived pluripotent stem cell, clone selected by the method and use of the clone |
| 05/18/2011 | EP2321354A1 Methods for identifying immunobinders of cell-surface antigens |
| 05/18/2011 | EP2321350A1 Antibodies against human epo receptor |
| 05/18/2011 | EP2321347A1 Methods and compositions for discovery of target-specific antibodies using antibody repertoire array (ara) |
| 05/18/2011 | EP2321340A1 Novel melanoma antigen peptide and uses thereof |
| 05/18/2011 | EP2321049A1 Microfluidic system |
| 05/18/2011 | EP2320932A2 Methods of predicting cancer lethality using replikin counts |
| 05/18/2011 | EP2320917A1 Methods of preventing, arresting or reversing tumourigenesis and of identifying compounds capable of the same |
| 05/18/2011 | EP2320898A2 Smoking cessation kit and method |
| 05/18/2011 | EP2320792A2 Breath test device and method |
| 05/18/2011 | EP2097752B1 Method for the purification of at least one target substance that is to be identified |
| 05/18/2011 | EP2089433B1 Therapy targeting cathepsin s |
| 05/18/2011 | EP1960077B1 Cation-exchange displacement chromatography process and cationic organic compounds for use as displacer compounds in cation-exchange displacement chromatography process |
| 05/18/2011 | EP1828779B1 Method for identifying modulators of the activity of ion-channels receptors |
| 05/18/2011 | EP1799715B1 Thyrotropin receptor preparations, binding regions thereof, antibody and hormone interactions therewith, and uses thereof |
| 05/18/2011 | EP1767936B1 Feces collection container |
| 05/18/2011 | EP1766011B1 Methods and uses of polypeptide ligands containing linkers |
| 05/18/2011 | EP1732950B1 Antibodies to erythropoietin receptor and uses thereof |
| 05/18/2011 | EP1662007B1 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient |
| 05/18/2011 | EP1613434B1 Measuring froth stability |
| 05/18/2011 | EP1565559B1 Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same |
| 05/18/2011 | EP1548425B1 Test kit |
| 05/18/2011 | EP1541998B1 Sample analyzing method and sample analyzing device |
| 05/18/2011 | EP1356298B1 Diagnosis of disease |
| 05/18/2011 | EP1274988B1 Narrow band infrared water fraction apparatus for gas well and liquid hydrocarbon flow stream use |
| 05/18/2011 | EP1255863B2 A homogenous method for detection of a polynucleotide, with e.g. cleavable lanthanide chelate label |
| 05/18/2011 | EP1131440B1 Process for oxidising terpenes |
| 05/18/2011 | EP1101111B1 Analyte test instrument system including data management system |
| 05/18/2011 | EP1091687B1 Biofeedback device for an incontinent person |
| 05/18/2011 | EP1021714B1 Method and apparatus for measuring lipid peroxidation in biological fluids and suspensions of tissues |
| 05/18/2011 | CN201837629U Indirect enzyme-linked immuno sorbent assay (ELISA) detection reagent kit for I type duck hepatitis virus antibodies |
| 05/18/2011 | CN201837628U Indirect enzyme-linked immunosorbnent assay (ELISA) detecting kit for goose parvovirus antibody |
| 05/18/2011 | CN201837627U Micropore plate dehydration device |
| 05/18/2011 | CN201837626U Multifunctional strickling rule for cement mortar experiment |
| 05/18/2011 | CN201837625U Automatic leaching device for soil column simulation experiments |
| 05/18/2011 | CN201837624U Combustible gas explosion limit testing system under non-standard states |
| 05/18/2011 | CN201837623U Detection and treatment system for detecting concentration of flammable gas in oil gas cavity of oil tank |
| 05/18/2011 | CN201837622U Driving wheel for wind-powered large-sized steel ball defectoscope |
| 05/18/2011 | CN201837621U Simulation device for evaluating cigarette filter material |
| 05/18/2011 | CN201837620U Simulated testing device for artificial sweat |
| 05/18/2011 | CN201837619U Harmful gas detecting device |
| 05/18/2011 | CN201837618U Cross rod turnover inspection device |
| 05/18/2011 | CN201837617U Clamping device for controlling cigarette air permeability |
| 05/18/2011 | CN201837418U High-precision wide-range integrated throttle device |
| 05/18/2011 | CN201836209U Roller shaft for wind-powered large-sized steel ball defectoscope |
| 05/18/2011 | CN201835871U Gas monitoring system |
| 05/18/2011 | CN1975432B Sampling and stirring integrated device for full-automatic biochemical analyser |
| 05/18/2011 | CN1971279B Oxoquinoxaline-2-carboxylic acid remained enzyme linked immunity detecting method and reagent kits |
| 05/18/2011 | CN1963507B Immune testing method for enzyme linked retained 3-methylquinoxaline-2-carboxylic acid and reagent set |
| 05/18/2011 | CN1961002B Binding molecules capable of neutralizing rabies virus and uses thereof |
| 05/18/2011 | CN1952664B Application of surface fatty acid-binding protein E-FABP |
| 05/18/2011 | CN1952663B Application of telomere enzyme binding protein p23 |
| 05/18/2011 | CN1952662B Application of star colloid cell phosphorylation protein PEA-15 |
| 05/18/2011 | CN1950695B Method and apparatus for testing gas sensor and calibrating output of gas sensor |
| 05/18/2011 | CN1945335B Reagent kit for detecting hepatitis B virus e antigen and use |
| 05/18/2011 | CN1928562B Enzyme linked immunoreaction reagent kit for detecting rabies virus |
| 05/18/2011 | CN1888902B Full closed target nucleic amplifier fast testing device |
| 05/18/2011 | CN1636506B Method of assessing skin and overall health of an individual |
| 05/18/2011 | CN1595154B Refined citric acid quantitative determination reagent |
| 05/18/2011 | CN102066974A Improved methods and compositions for F-18 labeling of proteins, peptides and other molecules |
| 05/18/2011 | CN102066950A Nucleic acid analyzer, automatic analyzer, and analysis method |
| 05/18/2011 | CN102066947A Method for determining factor causing the prolongation of blood coagulation time |
| 05/18/2011 | CN102066946A Prostatic disease evaluation method |
| 05/18/2011 | CN102066945A Modulators of STAT3 signalling |
| 05/18/2011 | CN102066944A Drug safety test using pentraxin-3 (PTX-3 ) |
| 05/18/2011 | CN102066943A Pro-endothelin-1 for the prediction of impaired peak oxygen consumption |
| 05/18/2011 | CN102066942A Method for a highly sensitive detection and quantification of biomolecules using secondary ion mass spectrometry (SIMS) and related technologies |
| 05/18/2011 | CN102066941A Novel Au / Ag core-shell composite useful for biosensor |
| 05/18/2011 | CN102066940A Cancer diagnosis based on levels of antibodies against Globo H and its fragments |
| 05/18/2011 | CN102066939A An assay to detect a gynecological condition |
| 05/18/2011 | CN102066938A Method for determination of edema associated with liver disease |
| 05/18/2011 | CN102066937A P53 biomarkers |
| 05/18/2011 | CN102066936A Assay method and device |